FGF23 and chronic kidney disease: Previous reports have shown that FGF-23 is an early marker of mineral disorder in chronic kidney disease, which has a phosphaturic effect (thus it promotes an increase of uFEP values) in order to avoid the development of hyperphosphatemia, which contributes to the progression of CKD [3,4].